{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "exchange": "PNK", "shortName": "ENZON PHARMACEUTICALS INC", "longName": "Enzon Pharmaceuticals, Inc.", "messageBoardId": "finmb_269599", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": 7.1974506, "regularMarketPrice": 0.1683, "firstTradeDateMilliseconds": 445703400000, "priceHint": 4, "fiftyTwoWeekLowChange": 0.008300006, "fiftyTwoWeekLowChangePercent": 0.05187504, "fiftyTwoWeekRange": "0.16 - 0.45", "fiftyTwoWeekHighChange": -0.2817, "fiftyTwoWeekHighChangePercent": -0.626, "fiftyTwoWeekLow": 0.16, "fiftyTwoWeekHigh": 0.45, "dividendDate": 1571097600, "earningsTimestamp": 1676581200, "earningsTimestampStart": 1676581200, "earningsTimestampEnd": 1676581200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 74214600, "bookValue": 0.046, "fiftyDayAverage": 0.2236, "fiftyDayAverageChange": -0.055299997, "fiftyDayAverageChangePercent": -0.24731663, "twoHundredDayAverage": 0.2701, "twoHundredDayAverageChange": -0.101799995, "twoHundredDayAverageChangePercent": -0.37689742, "marketCap": 13701539, "priceToBook": 3.6586957, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.011299998, "regularMarketTime": 1684252619, "regularMarketDayHigh": 0.1698, "regularMarketDayRange": "0.16675 - 0.1698", "regularMarketDayLow": 0.16675, "regularMarketVolume": 4000, "regularMarketPreviousClose": 0.157, "bid": 0.38, "ask": 1.41, "bidSize": 30, "askSize": 2, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.16675, "averageDailyVolume3Month": 14836, "averageDailyVolume10Day": 18010, "displayName": "Enzon Pharmaceuticals", "symbol": "ENZN"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "20 Commerce Drive", "address2": "Suite 135", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "732 980 4500", "website": "https://www.enzon.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard L. Feinstein", "age": 79, "title": "CEO, CFO & Company Sec.", "yearBorn": 1943, "fiscalYear": 2022, "totalPay": {"raw": 209452, "fmt": "209.45k", "longFmt": "209,452"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}